Due to this fact treatment of melanoma is mostly based in the development of immunotherapy for treatment of metastatic melanoma [3]. (jbiomed.com)
Immunotherapy is a promising approach in the treatment of metastatic melanoma, an aggressive and deadly form of skin cancer; but for most patients, immunotherapy drugs so far have failed to live up to their promise and provide little or no benefit. (sciencedaily.com)
Dr. Wolchok is the Lloyd J. Old / Virginia and Daniel K. Ludwig Chair in Clinical Investigation at Memorial Sloan Kettering Cancer Center (MSK); chief of the Melanoma and Immunotherapeutics Service at MSK; and an attending physician at MSK with expertise in the treatment of metastatic melanoma. (sciencemag.org)